Journalartikel

Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation


AutorenlisteBulinski, Catherine; Discher, Thomas; Rutsatz, Wiebke; Assmus, Birgit; Kraemer, Heidrun H.

Jahr der Veröffentlichung2022

Seiten3912-3914

ZeitschriftJournal of Neurology

Bandnummer269

Heftnummer7

ISSN0340-5354

eISSN1432-1459

Open Access StatusHybrid

DOI Linkhttps://doi.org/10.1007/s00415-022-10978-3

VerlagSpringer



Zitierstile

Harvard-ZitierstilBulinski, C., Discher, T., Rutsatz, W., Assmus, B. and Kraemer, H. (2022) Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation, Journal of Neurology, 269(7), pp. 3912-3914. https://doi.org/10.1007/s00415-022-10978-3

APA-ZitierstilBulinski, C., Discher, T., Rutsatz, W., Assmus, B., & Kraemer, H. (2022). Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation. Journal of Neurology. 269(7), 3912-3914. https://doi.org/10.1007/s00415-022-10978-3



Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 11:35